PLAC2 promotes proliferation and invasion of OSCC cells. (A) The transfection efficiency of knockdown or overexpression of PLAC2 was determined via reverse transcription-quantitative polymerase chain reaction. ***P<0.001, compared with the control groups. (B) Cell viability was assessed with an MTT assay in OSCC cells. *P<0.05, compared with the control groups. (C) Ki-67 protein level was measured in OSCC cells with an immunofluorescence assay. (D and E) Cell migration and invasion abilities were assessed in OSCC cells using wound-healing and Matrigel assays, respectively. *P<0.05, ***P<0.001, compared with the control groups. PLAC2, placenta-specific protein 2; OSCC, oral squamous cell carcinoma; si, small interfering; NC, negative control; p-NC, negative control overexpressed plasmid; p-PLAC2, PLAC2 overexpressed plasmid.